United Kingdom08/02/2023

EAHAD 2023

Octapharma Symposium

Share this page


Concomitant use of factor VIII and emicizumab in haemophilia A

Patient cases and clinical trials

Wednesday, 8 February 2023

17:15-18:30 GMT

Exchange Auditorium | Manchester, UK

Join our speakers for an interactive session as they follow three different patient cases. Together with you, they will explore the clinical and treatment journey of each patient from both the clinician and patient perspective.

Symposium agenda



Welcome and introduction

Chair: Guy Young, US

Choosing the right treatment strategy for previously untreated patients

Guy Young, US

A new frontier in inhibitor management*: an update from the MOTIVATE study

Carmen Escuriola Ettingshausen, DE

Controlling bleeding during surgery: clarifying the role of VIII

Steve Austin, UK

Q&A and concluding remarks

Speakers and audience

* as during the course of bleeding management

Meet the speakers

Guy Young

Children’s Hospital Los Angeles and Keck School of Medicine, University of Southern California​, Los Angeles, US

Carmen Escuriola Ettingshausen

Haemophilia Centre Rhein Main (HZRM) Mörfelden-Walldorf, DE

Steve Austin

St George's University Hospitals NHS Foundation Trust Guys and St Thomas’ NHS Foundation Trust, London, UK

To learn more about the congress, visit the EAHAD congress website.